2 unchanged sentences
The Company’s common stock, par value $0.001 per share, has traded on the Nasdaq Global Select Market under the symbol “SLP” since May 13, 2021, prior to which it traded on the Nasdaq Capital Market under the same symbol.
−Removed: As of October 18, 2024, there were 37 shareho lders of record.
+Added: As of November 14, 2025, there were 38 shareho lders of record.
A substantially greater number of holders of our common stock are “street name” or beneficial holders, whose shares are held by banks, brokers, and other financial institutions.
−Removed: On July 2, 2024, our Board of Directors declared a quarterly cash dividend of $0.06 per share to our shareholders.
−Removed: The dividend, with a dividend rate of $0.06 per share and an aggregate of approximately $1.2 million, was distributed on August 5, 2024 to the approximately 20 million shareholders of record as of July 29, 2024.
−Removed: Our Board of Directors has determined to discontinue the quarterly cash dividend historically paid by the Company, and to reallocate these funds to our capital allocation strategy for investing in growth initiatives that are intended to generate long-term shareholder value.
+Added: In 2024, our Board of Directors has determined to discontinue the quarterly cash dividend historically paid by the Company, and to reallocate these funds to our capital allocation strategy for investing in growth initiatives that are intended to generate long-term shareholder value.
We do not currently anticipate paying cash dividends on our common stock in the foreseeable future.
11 unchanged sentences
Shareholder Return Performance Graph
−Removed: The following graph compares the cumulative total stockholder return on Simulations-Plus, Inc.
−Removed: (SLP) common stock with the cumulative total return for the same period of SLP's Peer Groups (old and new).
−Removed: The graph assumes the investment of $100 as of August 31, 2019 and through August 31, 2024, assuming reinvestment of dividends.
+Added: The following graph compares the cumulative total shareholder return on Simulations-Plus, Inc.
+Added: (SLP) common stock with the cumulative total return for the same period of SLP's Peer Group.
+Added: The graph assumes the investment of $100 as of August 31, 2020, and through August 31, 2025, assuming reinvestment of dividends, with a similar investment in the S&P Small Cap 600 (“S&P Small Cap 600") and the S&P 600 Health Care Technology Industry Index (“SP600-351030").
The historical information set forth below is not necessarily indicative of future performance.
−Removed: In connection with filing this Report, the Company reassessed its peer group and determined that the companies included in the S&P Small Cap 600 (“S&P Small Cap 600-New”) and the S&P 600 Health Care Technology Industry Index (“SP600-351030-New”) more closely match our Company characteristics than the peer group the Company has previously included in its annual reports on Form 10-K, including companies listed on the Nasdaq Composite Total Returns (“NASDAQ-Old”), the Russell 3000 index (“Russell 3000-Old”), and SP600 Health Care Equipment & Service Industry Group Index (“SP600-3510-Old”).
This performance graph shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference into any of our filings under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
+Added: Simulations Plus was a constituent of the S&P SmallCap 600 through September 22, 2025.
+Added: Its subsequent removal from that index does not affect the historical comparison presented below.
+Added: These index returns are provided for reference only and do not imply current inclusion.
Recent Sales of Unregistered Securities;
8 unchanged sentences
After completion of the repurchases under the ASR Agreement, $30 million remains available for additional repurchases under our authorized repurchase program.
−Removed: The Company did not repurchase any shares of its common stock under its authorized repurchase program, or otherwise, during the fiscal year ended August 31, 2024.
+Added: The Company did not repurchase any shares of its common stock under its authorized repurchase program, or otherwise, during the fiscal years ended August 31, 2025, and August 31, 2024.
ITEM 6 – [RESERVED]
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.